“Novel roles for BRCA ½ and RAD51 tumor suppressors: Bridging the Gap Between Molecular Mechanisms and Cancer Therapies”

 Vincenzo Costanzo, MD, PhD

                            Professor of General Pathology

University of Milan

Investigator at IFOM, Milan, Italy